Latest Dexcom News & Updates

See the latest news and media coverage for Dexcom. We track all announcements, press releases, and industry mentions in real time, all in one place.

Dexcom

Manufacturer of continuous glucose monitoring systems

dexcom.com

Headquarters: San Diego, United States
Founded year: 1999
Company type: Public company
Number of employees: 10,000+

Last updated Today

Latest news about Dexcom

In short: Dexcom reported 15% Q1 revenue growth, launched the G8 sensor and over-the-counter Stelo for children, and acquired the CGM startup Nutrisense.

Company announcements

June 3 Dexcom

Dexcom reaffirms CGM benefits and continues momentum at ADA 2026

New CONNECT trial results, Stelo app redesign, and Nutrisense acquisition support earlier intervention and preventative care.

April 30 Dexcom

Dexcom reports Q1 2026 financial results

Revenue grows 15% to $1.192 billion. Operating income rises to $255.3 million. Raises 2026 guidance. Expands Dexcom G7 launch.

March 11 Dexcom

Dexcom showcases Type 2 outcomes and roadmap at ATTD 2026

Registry data shows G7 aids weight management and A1C reduction in non-insulin patients. Symposium shares upcoming features and CGM competency framework.

February 26 Dexcom

Dexcom appoints Rick Osterloh to Board of Directors

Effective February 26, 2026. Osterloh, Google's SVP of Platforms & Devices, brings expertise in innovation and strategic planning. CEO Jake Leach praises his product leadership alignment.

Media coverage

June 15 GuruFocus

DXCM Maintained by Piper Sandler -- Price Target Raised to $88

On June 15, 2026, Piper Sandler maintained an Overweight rating for DexCom (DXCM) while raising the price target to $88 from $75. This adjustment marks...

June 12 U.S. News & World Report

FDA Approves First Over-the-Counter Glucose Monitor for Children

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news...

June 12 Yahoo Finance

DexCom Expands Beyond CGMs With CONNECT Results AI Apps And Nutrisense Deal

DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous...

June 11 Law360

DexCom Says Diabetes Tech Issue Isn't Investor Fraud - Law360

Medical device maker DexCom Inc. has urged a New York federal judge to toss a proposed investor class action over the reliability of the company's...

Never miss news about Dexcom

Track Dexcom and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Dexcom competitors & trending companies

Browse news for competitors to Dexcom and other trending companies.